Your session is about to expire
β Back to Search
Infants for Premature Birth
N/A
Recruiting
Led By Jonathan Strutt
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients admitted to the NICU at the University of Minnesota Masonic Children's Hospital, Minneapolis, MN requiring placement of an NG/OG tube are eligible to enroll.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PH reading comparison
Trial Design
1Treatment groups
Experimental Treatment
Group I: InfantsExperimental Treatment1 Intervention
Infants admitted to the University of Minnesota Masonic Children's Hospital neonatal intensive care unit.
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,379 Previous Clinical Trials
1,588,462 Total Patients Enrolled
10 Trials studying Premature Birth
1,143 Patients Enrolled for Premature Birth
Jonathan StruttPrincipal InvestigatorUniversity of Minnesota
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger